Molecular bases of cystic fibrosis [PDF]
, 2020 RESUMEN : La fibrosis quística (FQ) es una enfermedad monogénica autosómica recesiva con una prevalencia de 1/2500-3500 nacidos vivos. En 1989 se descubrió el gen CFTR responsable de la enfermedad: gen regulador de la conductancia transmembrana ...
Petitta, Benedetta
core
Targeting MEP pathway for the development of antitubercular drugs [PDF]
, 2022 Thesis (MSc)--Stellenbosch University, 2022.ENGLISH ABSTRACT: Background: Tuberculosis (TB) still remains a global health burden with an estimated 1.4 million mortalities in 2019.
Maila, Tumelo
core +1 more source
In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection. [PDF]
Ann Lab Med, 2023 Park JS +8 more
europepmc +1 more source
Antimicrobial Effect of Oxazolidinones and Its Synergistic Effect with Bedaquiline Against Mycobacterium abscessus Complex. [PDF]
Infect Drug Resist, 2023 Gao T +9 more
europepmc +1 more source
Treatment of Buruli ulcer: research, development, and repurposing of new therapeutics targeting Mycobacterium ulcerans [PDF]
Tese de doutoramento em Ciências da SaúdeMycobacterium ulcerans é o agente patogénico responsável pela Úlcera de Buruli, uma doença infeciosa tropical negligenciada.
Dominguez Enriquez, Juan Pablo
core
Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection. [PDF]
Pharmaceutics, 2023 Shleider Carnero Canales C +7 more
europepmc +1 more source
Innovate to Eradicate:Refining Tuberculosis Drug Discovery through Zebrafish [PDF]
Tuberculosis (TB) remains one of the oldest and most persistent infectious diseases, posing a significant global health challenge with over 10 million new infections annually.
Habjan, Eva
core +1 more source
Staph wars: the antibiotic pipeline strikes back. [PDF]
Microbiology (Reading), 2023 Douglas EJA, Laabei M.
europepmc +1 more source
Investigation of antibiotic targets in the decaprenyl-phosphorylarabinose biosynthesis in m. tuberculosis [PDF]
, 2019 An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life on a global-scale. To shorten current treatments and battle drug resistant strains it is important to discover and develop new drugs against the causative
Tóth, Szilvia
core
The activity of nybomycin against mycobacterium tuberculosis. [PDF]
, 2018 Doctoral Degree. University of KwaZulu-Natal, Durban.Nybomycin was discovered in 1955, but was never developed for clinical use. The compound was noticed again in recent years when it displayed bactericidal activity against certain fluoroquinolone ...
Niehaus, Abraham Johannes.
core